AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

A research team has identified the impact of stem cell infusion timing on the incidence and severity of acute ...

Researchers at Keio University have begun using induced pluripotent stem cells (iPS) to treat and maybe even cure severe ...

In this webinar, Michael Longaker and Maksim Plikus will discuss stem cell approaches for wound healing and skin regeneration ...

Mar. 11, 2025 — Researchers have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells. Understanding the differences ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

O rgan transplants are a familiar idea. Organelle transplants, less so. Yet organelles are to cells what organs are to bodies ...

A Penn Medicine neurologist was awarded the 2025 John Dystel Prize for his research on immune cells and how they interact to ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science of addressing critical issues with CAR T cell therapy in patients with ...

Checkpoint Therapeutics, Inc. ("Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, ...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...

Discover how blood stem cells release IL-10 to regulate inflammation and protect bone marrow, offering new therapeutic ...